AUSTIN, Texas, March 08, 2018 -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that its management will provide a corporate overview at the Cowen and Company 38th Annual Health Care Conference, taking place March 12-14 at the Boston Marriott Copley Place in Boston, MA.
| Presentation Details | |
| Date: | Tuesday, March 13 |
| Time: | 11:20am Eastern Time |
| Location: | The Boston Marriott Copley Place |
| Webcast: | http://wsw.com/webcast/cowen46/mtem/ |
About Molecular Templates
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at www.mtem.com.
Investor Contact:
Andrew McDonald, Ph.D.
andrew@lifesciadvisors.com
646-597-6987
Adam Cutler
Chief Financial Officer
adam.cutler@mtem.com
862-204-4006
